MMMarwa Madi

Marwa Madi

*This is an algorithmically generated author record based on publicly available information.

Marwa Madi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Behavioral Determinants of Adult Hearing Health Care Engagement Across the Care Pathway: A Scoping Review Using the Capability, Opportunity, Motivation–Behavior Framework

    by Muhammed Ayas, Marwa Madi

    Purpose: The aim of this study was to identify behavioral determinants influencing adult hearing health care engagement across the hearing health care pathway and to map these determinants to the Capability, Opportunity, Motivation–Behavior (COM-B) framework. Method: A scoping review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Electronic searches of PubMed/MEDLINE, Scopus, CINAHL, and Web of Science identified 767 records. Fourteen studies involving adults with hearing loss or hearing difficulties met inclusion criteria. Results: Determinants were identified across multiple stages of the hearing health care pathway, revealing stage-specific behavioral influences and evidence gaps across the engagement continuum. Determinants were mapped to the six domains of the COM-B framework. Reflective motivation was represented in all included studies, while social opportunity, physical opportunity, and psychological capability were also frequently reported. Evidence was concentrated at the treatment adoption stage, with comparatively limited research addressing earlier pathway stages or longitudinal behavioral transitions. Conclusions: Adult hearing health care engagement is shaped by interacting motivational, social, capability-related, and structural determinants across the care pathway. A COM-B–informed synthesis provides a behavioral framework for understanding where engagement may break down and for guiding stage-specific interventions to improve help-seeking, treatment uptake, and sustained engagement with hearing technologies. Supplemental Material: https://doi.org/10.23641/asha.34930449

  • Open Access

    Remote cochlear implant programming: a systematic review of clinical effectiveness and implementation outcomes

    by Muhammed Ayas, Jameel Muzaffar, Marwa Madi, Ahmad AlAmadi, Mira Koleva, Manohar L. Bance

    Purpose Remote cochlear implant (CI) programming is increasingly used to expand access to follow-up care. This systematic review evaluated the clinical effectiveness and implementation outcomes of synchronous, asynchronous and hybrid remote CI programming in adults and children. Methods PubMed, Embase, Scopus, CINAHL and the Cochrane Library were searched from January 2010 to July 2025. Eligible studies were randomised or observational designs reporting clinical outcomes (speech perception, aided thresholds, impedances, threshold/comfort levels) and/or implementation outcomes (feasibility, satisfaction, technical performance). Two reviewers independently screened, extracted data and assessed risk of bias. Given heterogeneity in design and outcomes, a narrative synthesis was conducted. Results Eleven studies (n = 356 CI recipients) met inclusion criteria. Across comparator studies, remote programming produced no clinically meaningful differences relative to in-person programming for speech perception (7/7 studies) or aided thresholds (5/5), and programming parameters remained stable (5/5). Feasibility was high, with session-completion rates typically ≥ 85%. CI recipients and clinicians reported favourable satisfaction, citing reduced travel burden and increased flexibility. Key challenges included intermittent connectivity, need for additional preparation or troubleshooting, limited digital literacy among older adults, and caregiver dependency in paediatric sessions. Conclusion Remote CI programming yields clinical outcomes comparable to in-person programming and is feasible and well accepted across delivery models. However, small sample sizes, limited paediatric evidence, inconsistent technical reporting and a lack of cost-effectiveness data limit confidence in large-scale adoption. Standardised technical endpoints and rigorous multicentre evaluations are required to support scalable and equitable implementation.